Norges Bank Pfizer Inc Transaction History

Norges Bank

$655 Billion
Q2 2024

A detailed history of Norges Bank transactions in Pfizer Inc stock. As of the latest transaction made, Norges Bank holds 83,963,188 shares of PFE stock, worth $2.31 Billion. This represents 0.36% of its overall portfolio holdings.

Number of Shares

83,963,188

Holding current value

$2.31 Billion

% of portfolio

0.36%

48 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $2.12 Billion - $2.49 Billion	83,963,188 New	83,963,188 $2.35 Billion
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $1.93 Billion - $2.51 Billion	73,981,480 New	73,981,480 $2.13 Billion
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $1.86 Billion - $2.17 Billion	-57,824,141 Closed	0 $0
Q2 2023 Aug 14, 2024	SELL	$36.12 - $41.79 $624 Million - $722 Million	-17,271,701 Reduced 20.57%	66,691,487 $2.45 Billion
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $2.04 Billion - $2.36 Billion	-56,552,841 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$39.39 - $51.28 $2.55 Billion - $3.32 Billion	64,661,968 New	64,661,968 $2.64 Billion
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $2.57 Billion - $3.35 Billion	61,484,622 New	61,484,622 $3.15 Billion
Q3 2022 Nov 13, 2023	BUY	$43.76 - $53.42 $2.53 Billion - $3.09 Billion	57,824,141 New	57,824,141 $2.53 Billion
Q2 2022 Aug 14, 2023	BUY	$46.53 - $55.17 $2.63 Billion - $3.12 Billion	56,552,841 New	56,552,841 $2.97 Billion
Q1 2022 May 12, 2023	SELL	$45.75 - $56.69 $226 Million - $280 Million	-4,933,837 Reduced 8.02%	56,550,785 $2.93 Billion
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $2.6 Billion - $3.22 Billion	-56,763,604 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$41.32 - $61.25 $2.35 Billion - $3.48 Billion	56,763,604 New	56,763,604 $3.35 Billion
Q3 2021 Nov 14, 2022	BUY	$39.25 - $50.42 $2.22 Billion - $2.85 Billion	56,562,810 New	56,562,810 $2.43 Billion
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $2.31 Billion - $2.97 Billion	-58,887,805 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$35.91 - $40.68 $2.11 Billion - $2.4 Billion	58,887,805 New	58,887,805 $2.31 Billion
Q2 2021 Aug 10, 2021	SELL	$35.91 - $40.68 $2.21 Billion - $2.51 Billion	-61,629,341 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$33.49 - $37.77 $2.06 Billion - $2.33 Billion	61,629,341 New	61,629,341 $2.23 Billion
Q1 2021 May 07, 2021	SELL	$33.49 - $37.77 $2.02 Billion - $2.28 Billion	-60,296,992 Closed	0 $0
Q4 2020 Mar 02, 2021	BUY	$33.47 - $42.56 $2.02 Billion - $2.57 Billion	60,296,992 New	60,296,992 $2.22 Billion
Q4 2020 Feb 10, 2021	SELL	$33.47 - $42.56 $1.95 Billion - $2.48 Billion	-58,184,627 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$31.75 - $37.25 $1.85 Billion - $2.17 Billion	58,184,627 New	58,184,627 $2.14 Billion
Q3 2020 Nov 10, 2020	SELL	$31.75 - $37.25 $1.86 Billion - $2.18 Billion	-58,649,481 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$30.12 - $36.54 $1.77 Billion - $2.14 Billion	58,649,481 New	58,649,481 $1.92 Billion
Q2 2020 Aug 07, 2020	SELL	$30.12 - $36.54 $1.79 Billion - $2.17 Billion	-59,372,776 Closed	0 $0
Q1 2020 May 07, 2021	BUY	$27.03 - $38.62 $1.6 Billion - $2.29 Billion	59,372,776 New	59,372,776 $1.94 Billion
Q1 2020 May 08, 2020	SELL	$27.03 - $38.62 $1.6 Billion - $2.29 Billion	-59,372,776 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$32.92 - $37.36 $1.95 Billion - $2.22 Billion	59,372,776 New	59,372,776 $2.33 Billion
Q4 2019 Feb 12, 2020	SELL	$32.92 - $37.36 $1.96 Billion - $2.23 Billion	-59,678,571 Closed	0 $0
Q3 2019 Nov 13, 2020	BUY	$32.49 - $42.13 $1.94 Billion - $2.51 Billion	59,678,571 New	59,678,571 $2.14 Billion
Q3 2019 Nov 08, 2019	SELL	$32.49 - $42.13 $1.93 Billion - $2.5 Billion	-59,309,663 Closed	0 $0
Q2 2019 Aug 13, 2020	BUY	$36.98 - $41.52 $2.19 Billion - $2.46 Billion	59,309,663 New	59,309,663 $2.57 Billion
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $2.23 Billion - $2.5 Billion	-60,277,153 Closed	0 $0
Q1 2019 May 11, 2020	BUY	$37.5 - $41.2 $87.3 Million - $95.9 Million	2,326,984 Added 4.02%	60,277,153 $2.56 Billion
Q4 2018 Mar 04, 2019	BUY	$38.47 - $43.86 $2.23 Billion - $2.54 Billion	57,950,169 New	57,950,169 $2.53 Billion
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $2.19 Billion - $2.5 Billion	-56,962,554 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$34.47 - $41.81 $1.96 Billion - $2.38 Billion	56,962,554 New	56,962,554 $2.51 Billion
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $1.96 Billion - $2.38 Billion	-56,912,021 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$32.98 - $35.16 $1.88 Billion - $2 Billion	56,912,021 New	56,912,021 $2.06 Billion
Q2 2018 Jul 23, 2018	SELL	$32.98 - $35.16 $1.91 Billion - $2.03 Billion	-57,838,101 Closed	0 $0
Q1 2018 May 15, 2019	BUY	$31.91 - $37.02 $1.85 Billion - $2.14 Billion	57,838,101 New	57,838,101 $2.05 Billion
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $1.84 Billion - $2.13 Billion	-57,562,847 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$33.26 - $35.29 $1.91 Billion - $2.03 Billion	57,562,847 New	57,562,847 $2.08 Billion
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $1.93 Billion - $2.05 Billion	-57,979,234 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$31.0 - $34.15 $1.8 Billion - $1.98 Billion	57,979,234 New	57,979,234 $2.07 Billion
Q3 2017 Nov 07, 2017	SELL	$31.0 - $34.15 $1.8 Billion - $1.98 Billion	-58,088,526 Closed	0 $0
Q2 2017 Jul 24, 2018	SELL	N/A	-2,066,246 Reduced 3.43%	58,088,526 $1.95 Billion
Q1 2017 May 11, 2018	BUY	N/A	3,479,506 Added 6.14%	60,154,772 $2.06 Billion
Q3 2016 Nov 13, 2017	BUY	N/A	56,675,266	56,675,266 $0

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$14 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.7 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.88 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.57 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.22 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account